FDA Commissioner Dr. Robert Califf Discusses the Top News Stories episode artwork

EPISODE · Mar 29, 2023 · 27 MIN

FDA Commissioner Dr. Robert Califf Discusses the Top News Stories

from Conversations on Health Care

Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic.He addresses the FDA's pending new tobacco control rules, as well as improvements to the infant formula pipeline in the wake of recent shortages. Dr. Califf also voices deep concerns that health misinformation is the 'leading cause of death in America now.'See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode metadata supplied by the publisher feed · Published Mar 29, 2023

Embed this episode

Ready to play

FDA Commissioner Dr. Robert Califf Discusses the Top News Stories

0:00 27:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Conversations on Health Care?

This episode is 27 minutes long.

When was this Conversations on Health Care episode published?

This episode was published on March 29, 2023.

Can I download this Conversations on Health Care episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!